Author

Clara Moniz

SERUM LEVELS OF INFLIXIMAB AND ADALIMUMAB BIOSIMILARS CAN BE MEASURED EQUIVALENTLY TO ORIGINATOR DRUGS BY QUANTUM BLUE RAPID TESTING AS TOOL FOR THERAPEUTIC DRUG MONITORING
SERUM LEVELS OF INFLIXIMAB AND ADALIMUMAB BIOSIMILARS CAN BE MEASURED EQUIVALENTLY TO ORIGINATOR DRUGS BY QUANTUM BLUE RAPID TESTING AS TOOL FOR THERAPEUTIC DRUG MONITORING

Clara Moniz  et al.

Item 1 - 1 / 1
1